KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Capital Expenditures (2018 - 2025)

Historic Capital Expenditures for Moderna (MRNA) over the last 8 years, with Q3 2025 value amounting to $33.0 million.

  • Moderna's Capital Expenditures fell 7814.57% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $675.0 million, marking a year-over-year decrease of 987.98%. This contributed to the annual value of $1.1 billion for FY2024, which is 4865.63% up from last year.
  • Latest data reveals that Moderna reported Capital Expenditures of $33.0 million as of Q3 2025, which was down 7814.57% from $3.0 million recorded in Q2 2025.
  • In the past 5 years, Moderna's Capital Expenditures ranged from a high of $522.0 million in Q4 2024 and a low of $3.0 million during Q2 2025
  • For the 5-year period, Moderna's Capital Expenditures averaged around $136.6 million, with its median value being $117.0 million (2025).
  • As far as peak fluctuations go, Moderna's Capital Expenditures surged by 42105.26% in 2021, and later plummeted by 9835.16% in 2025.
  • Moderna's Capital Expenditures (Quarter) stood at $120.0 million in 2021, then fell by 23.33% to $92.0 million in 2022, then surged by 139.13% to $220.0 million in 2023, then soared by 137.27% to $522.0 million in 2024, then plummeted by 93.68% to $33.0 million in 2025.
  • Its Capital Expenditures stands at $33.0 million for Q3 2025, versus $3.0 million for Q2 2025 and $117.0 million for Q1 2025.